A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.

Sandeep Moola, Nachiket Gudi, Devaki Nambiar, Neha Dumka, Tarannum Ahmed, Isha Ramesh Sonawane, Atul Kotwal
Author Information
  1. Sandeep Moola: George Institute for Global Health, Hyderabad, India.
  2. Nachiket Gudi: PATH, Bengaluru, India.
  3. Devaki Nambiar: George Institute for Global Health, New Delhi, India.
  4. Neha Dumka: The National Health Systems Resource Centre, New Delhi, India.
  5. Tarannum Ahmed: The National Health Systems Resource Centre, New Delhi, India.
  6. Isha Ramesh Sonawane: The National Health Systems Resource Centre, New Delhi, India.
  7. Atul Kotwal: The National Health Systems Resource Centre, New Delhi, India.

Abstract

BACKGROUND: Vaccine acceptance and hesitancy among the general population and health care workers play an important role in successfully controlling the Coronavirus Disease (COVID)-19 pandemic. While there is evidence for vaccine hesitancy across the globe, wide variation in factors influencing vaccine acceptance has been reported, mainly from High-Income Countries (HIC). However, the evidence from Low- and Middle-Income Countries (LMICs) remains unclear. The objective of this review was to describe the determinants of vaccine acceptance and strategies to address those in an LMIC context.
METHODS: The World Health Organization's (WHO) Measuring Behavioral and Social Drivers of Vaccination (BeSD) Increasing Vaccination Model was employed to identify factors that influenced vaccine acceptance. All evidence related to supply-side and demand-side determinants and social and health system processes were examined. A comprehensive search for published literature was conducted in three databases and grey literature in relevant websites of government, multinational agencies, and COVID-19 resource aggregators, followed by a narrative synthesis.
RESULTS: Overall, the results showed that the vaccine acceptance rates differed across LMICs, with a wide variety of reasons cited for vaccine hesitancy. Vaccine acceptance was reportedly greater among males, those with higher education, elevated socio-economic status, the unmarried, those employed as health care workers. Evidence suggested that exposure to misinformation about COVID-19 vaccines and public concerns over the safety of vaccines may contribute to lower acceptance rates. Strategies to increase vaccine acceptance rates included direct engagement with communities through influencers, including community leaders and health experts; clear and transparent communication about COVID-19 vaccines, financial and non-financial incentives; and strong endorsement from health care workers. Trust in government was identified as a significant enabler of vaccine acceptance.
CONCLUSIONS: There is a need for measures to address public acceptability, trust and concern over the safety and benefit of approved vaccines. Local context is essential to consider while developing programs to promote vaccine uptake. The governments worldwide also need to strategize to develop plans to address the anxiety and vaccine related concerns of community regarding vaccine hesitancy. There is a need for further research to evaluate strategies to address vaccine hesitancy in LMIC.

References

  1. Nat Rev Immunol. 2021 Apr;21(4):198-199 [PMID: 33712744]
  2. Eur J Epidemiol. 2020 Apr;35(4):325-330 [PMID: 32318915]
  3. Vaccines (Basel). 2021 Mar 12;9(3): [PMID: 33809002]
  4. PLoS One. 2021 Dec 9;16(12):e0260821 [PMID: 34882726]
  5. Infect Dis Ther. 2020 Sep;9(3):421-432 [PMID: 32447713]
  6. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  7. Vaccines (Basel). 2021 May 17;9(5): [PMID: 34067682]
  8. Pan Afr Med J. 2021 Mar 02;38:230 [PMID: 34046135]
  9. Hum Vaccin Immunother. 2016 Apr 2;12(4):1045-50 [PMID: 26577532]
  10. BMJ Open. 2022 May 30;12(5):e052432 [PMID: 35636790]
  11. Am J Trop Med Hyg. 2020 Aug;103(2):603-604 [PMID: 32588810]
  12. Infect Drug Resist. 2011;4:197-207 [PMID: 22114512]
  13. Arch Dis Child. 2021 Feb;106(2):113-114 [PMID: 32912868]
  14. Vaccines (Basel). 2020 Jun 17;8(2): [PMID: 32560340]
  15. Vaccines (Basel). 2020 Dec 30;9(1): [PMID: 33396832]
  16. Hum Vaccin Immunother. 2018;14(10):2391-2396 [PMID: 29923787]
  17. J Family Med Prim Care. 2021 Jun;10(6):2369-2375 [PMID: 34322440]
  18. PLoS One. 2021 Sep 15;16(9):e0257237 [PMID: 34525110]
  19. R Soc Open Sci. 2020 Oct 14;7(10):201199 [PMID: 33204475]
  20. J Health Commun. 2020 Oct 2;25(10):799-807 [PMID: 33719881]
  21. Front Public Health. 2021 Feb 10;9:632914 [PMID: 33643995]
  22. PLoS One. 2021 Apr 27;16(4):e0250495 [PMID: 33905442]
  23. Am J Prev Med. 2020 Oct;59(4):493-503 [PMID: 32778354]
  24. BMJ Open. 2021 Aug 24;11(8):e050303 [PMID: 34429316]
  25. Vaccines (Basel). 2021 Apr 01;9(4): [PMID: 33915829]
  26. Vaccine. 2015 Aug 14;33(34):4176-9 [PMID: 25896376]
  27. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  28. Vaccine. 2019 Mar 7;37(11):1495-1502 [PMID: 30755367]
  29. Lancet Oncol. 2019 Nov;20(11):e637-e644 [PMID: 31674322]

MeSH Term

COVID-19
COVID-19 Vaccines
Developing Countries
Humans
Male
Patient Acceptance of Health Care
SARS-CoV-2
Vaccination Hesitancy

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccineacceptancehesitancyhealthevidenceaddressCOVID-19vaccinescareworkersdeterminantsstrategiesratesneedVaccineamongacrosswidefactorsCountriesLMICsreviewLMICcontextVaccinationemployedrelatedliteraturegovernmentpublicconcernssafetycommunityBACKGROUND:generalpopulationplayimportantrolesuccessfullycontrollingCoronavirusDiseaseCOVID-19pandemicglobevariationinfluencingreportedmainlyHigh-IncomeHICHoweverLow-Middle-IncomeremainsunclearobjectivedescribeMETHODS:WorldHealthOrganization'sWHOMeasuringBehavioralSocialDriversBeSDIncreasingModelidentifyinfluencedsupply-sidedemand-sidesocialsystemprocessesexaminedcomprehensivesearchpublishedconductedthreedatabasesgreyrelevantwebsitesmultinationalagenciesresourceaggregatorsfollowednarrativesynthesisRESULTS:Overallresultsshoweddifferedvarietyreasonscitedreportedlygreatermaleshighereducationelevatedsocio-economicstatusunmarriedEvidencesuggestedexposuremisinformationmaycontributelowerStrategiesincreaseincludeddirectengagementcommunitiesinfluencersincludingleadersexpertscleartransparentcommunicationfinancialnon-financialincentivesstrongendorsementTrustidentifiedsignificantenablerCONCLUSIONS:measuresacceptabilitytrustconcernbenefitapprovedLocalessentialconsiderdevelopingprogramspromoteuptakegovernmentsworldwidealsostrategizedevelopplansanxietyregardingresearchevaluaterapidlow-middle-incomecountries

Similar Articles

Cited By